---
figid: PMC7369697__ijms-21-04576-g001
figlink: pmc/articles/PMC7369697/figure/ijms-21-04576-f001/
number: Figure 1
caption: BRAF signaling pathway including abnormal signaling from BRAFV600E mutated
  proteins. The scheme also shows inhibitors and their targets—drugs approved in melanoma
  treatment are bolded, we also show other potential inhibitors (drugs in development
  or registered in other indications). RTK–receptor tyrosine kinase; RTKs–receptor
  tyrosine kinases; BRAF–proto-oncogene B-Raf; BRAFi–BRAF inhibitors; ARAF–serine/threonine-protein
  kinase A-Raf; CRAF–RAF proto-oncogene serine/threonine-protein kinase, also known
  as proto-oncogene c-RAF; PI3K–phosphoinositide 3-kinases; P–phosphoprotein; MEK–mitogen-activated
  protein kinase kinase; ERK–extracellular-signal-regulated kinase; COT–mitogen-activated
  protein kinase kinase kinase 8 or serine/threonine-protein kinase cot-1; MCL-1–induced
  myeloid leukemia cell differentiation protein Mcl-1; AKT–protein kinase B, also
  known as Akt; Rb–the retinoblastoma protein; Bad–BCL2 associated agonist of cell
  death; c-Myc–Myc proto-oncogene protein; c-Jun–Jun-related antigen, isoform C; Ets–ETS
  transcription factor family; c-Fos–proto-oncogene c-Fos.
pmcid: PMC7369697
papertitle: Targeted Therapy in Melanoma and Mechanisms of Resistance.
reftext: Anna M. Czarnecka, et al. Int J Mol Sci. 2020 Jul;21(13):4576.
pmc_ranked_result_index: '64846'
pathway_score: 0.96442
filename: ijms-21-04576-g001.jpg
figtitle: BRAF signaling pathway including abnormal signaling from BRAFV600E mutated
  proteins
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7369697__ijms-21-04576-g001.html
  '@type': Dataset
  description: BRAF signaling pathway including abnormal signaling from BRAFV600E
    mutated proteins. The scheme also shows inhibitors and their targets—drugs approved
    in melanoma treatment are bolded, we also show other potential inhibitors (drugs
    in development or registered in other indications). RTK–receptor tyrosine kinase;
    RTKs–receptor tyrosine kinases; BRAF–proto-oncogene B-Raf; BRAFi–BRAF inhibitors;
    ARAF–serine/threonine-protein kinase A-Raf; CRAF–RAF proto-oncogene serine/threonine-protein
    kinase, also known as proto-oncogene c-RAF; PI3K–phosphoinositide 3-kinases; P–phosphoprotein;
    MEK–mitogen-activated protein kinase kinase; ERK–extracellular-signal-regulated
    kinase; COT–mitogen-activated protein kinase kinase kinase 8 or serine/threonine-protein
    kinase cot-1; MCL-1–induced myeloid leukemia cell differentiation protein Mcl-1;
    AKT–protein kinase B, also known as Akt; Rb–the retinoblastoma protein; Bad–BCL2
    associated agonist of cell death; c-Myc–Myc proto-oncogene protein; c-Jun–Jun-related
    antigen, isoform C; Ets–ETS transcription factor family; c-Fos–proto-oncogene
    c-Fos.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - KRAS
  - NRAS
  - BRAF
  - ARAF
  - RAF1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - MAP2K1
  - MAP2K2
  - CROT
  - MAPK3
  - MAPK1
  - AKT2
  - AKT3
  - AKT1
  - MCL1
  - ETS1
  - ETS2
  - FOS
  - BAD
  - CASP1
  - CASP2
  - CASP8
  - CASP9
  - CASP14
  - CASP12
  - CASP3
  - CASP4
  - CASP5
  - CASP6
  - CASP7
  - CASP10
  - JUN
  - MYC
  - Imatinib
  - Sunitinib
  - Vemurafenib
  - Dabrafenib
  - Encorafenib
  - Trametinib
  - Cobimetinib
  - Selumetinib
  - Binimetinib
  - Uprosertib
  - MK-2206
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ARAF
  symbol: ARAF
  source: hgnc_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: CRAF
  symbol: CRAF
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: COT
  symbol: COT
  source: hgnc_alias_symbol
  hgnc_symbol: CROT
  entrez: '54677'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT)
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT)
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT)
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MCL-1
  symbol: MCL1
  source: hgnc_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: Ets
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: Ets
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS2
  entrez: '2114'
- word: C-Fos
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: Bad
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: MCL-1
  symbol: MCL1
  source: hgnc_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: c-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: с-Мус
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
chemicals:
- word: Imatinib
  source: MESH
  identifier: C097613
- word: Sunitinib
  source: MESH
  identifier: C473478
- word: Vemurafenib
  source: MESH
  identifier: C551177
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: Encorafenib
  source: ''
  identifier: ''
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Cobimetinib
  source: MESH
  identifier: C574276
- word: Selumetinib
  source: MESH
  identifier: C517975
- word: Binimetinib
  source: MESH
  identifier: C581313
- word: Uprosertib
  source: ''
  identifier: ''
- word: MK-2206
  source: MESH
  identifier: C548887
diseases: []
---
